We are live on ! Find out more
NTCM

Nine Ten Capital Management Portfolio holdings

AUM $315M
1-Year Est. Return 62.95%
This Fund
S&P 500
This Quarter Est. Return
+24.97%
1 Year Est. Return
+62.95%
3 Year Est. Return
+88.95%
5 Year Est. Return
+99.78%
10 Year Est. Return
+1,599.35%
AUM
$327M
AUM Growth
-$14.1M
Cap. Flow
-$85.5M
Cap. Flow %
-26.15%
Top 10 Hldgs %
100%
Holding
10
New
Increased
2
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
TRUP icon
Trupanion
TRUP
+$3.92M
2
INST
Instructure, Inc.
INST
+$361K

Top Sells

Rank Stock Value
1
XPO icon
XPO
XPO
+$70.1M
2
WINA icon
Winmark
WINA
+$7.09M
3
MLAB icon
Mesa Laboratories
MLAB
+$4.47M
4
OFLX icon
Omega Flex
OFLX
+$4.12M
5
UTMD icon
Utah Medical Products
UTMD
+$3.7M

Sector Composition

Rank Sector Weight
1 Industrials 29.21%
2 Financials 16.67%
3 Technology 15.95%
4 Consumer Discretionary 14.31%
5 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
1
DELISTED
Instructure, Inc.
INST
$78M 23.86%
2,645,324
+14,200
+0.5% +$361K
XPO icon
2
XPO
XPO
$25B
$48.2M 14.74%
2,156,945
-3,741,545
-63% -$70.1M
WINA icon
3
Winmark
WINA
$1.19B
$46.8M 14.31%
363,001
-56,044
-13% -$7.09M
TTGT icon
4
TechTarget
TTGT
$246M
$30.6M 9.37%
2,953,648
TRUP icon
5
Trupanion
TRUP
$1.05B
$29.8M 9.1%
1,329,867
+217,487
+20% +$3.92M
SNEX icon
6
StoneX
SNEX
$8.83B
$24.7M 7.56%
3,316,682
-50,625
-2% -$364K
OFLX icon
7
Omega Flex
OFLX
$298M
$24.3M 7.44%
377,919
-71,265
-16% -$4.12M
REIS
8
DELISTED
Reis, Inc.
REIS
$23M 7.03%
1,081,227
MLAB icon
9
Mesa Laboratories
MLAB
$539M
$21.5M 6.58%
150,210
-31,445
-17% -$4.47M
UTMD icon
10
Utah Medical Products
UTMD
$214M
-59,371
Closed -$3.7M

Similar funds

Nine Ten Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Nine Ten Capital Management held 10 positions worth $327M, down 4.1% from $341M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Nine Ten Capital Management withdrew a net $85.5M in Q2 2017, closing 1 position and reducing 5 holdings. Its most notable exit was Utah Medical Products, an estimated $3.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 41% a quarter earlier, followed by Financials and Technology.

Against the trend, Nine Ten Capital Management added an estimated $3.92M to Trupanion.

  • Nine Ten Capital Management added most to Trupanion in Q2 2017, an estimated $3.92M increase.
  • Nine Ten Capital Management's biggest Q2 2017 reduction was XPO, cutting an estimated $70.1M.
  • Nine Ten Capital Management fully exited Utah Medical Products in Q2 2017, selling an estimated $3.7M.
  • Nine Ten Capital Management's ten largest holdings make up 100% of its $327M portfolio in Q2 2017.
  • Nine Ten Capital Management opened 0 new positions and closed 1 in Q2 2017.
  • Nine Ten Capital Management's portfolio value fell 4.1% quarter-over-quarter to $327M.

Based on Nine Ten Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.